Peanut Allergy Immunotherapy Research Trial for Adults (Sydney)
RESEARCH OPPORTUNITY – Peanut Allergy Immunotherapy Research Trial for Adults (Sydney)
Are you an adult living with a severe peanut allergy? Do you have a child over the age of 16 with a severe peanut allergy?
St Vincent’s Hospital in Sydney is now recruiting for their peanut allergy immunotherapy research trial (OPAL study).
Peanut oral immunotherapy involves consuming small but increasing amounts of peanut over time to help build tolerance. The study is using an anti-allergy medication (omalizumab) together with peanut oral immunotherapy (also known as desensitisation), to understand whether peanut immunotherapy will be safer, quicker and more tolerable.
Please note all study visits will be conducted at St Vincent's Hospital in Sydney.